Discussions on Emerging Concepts and Controversies in the Treatment of Patients With Advanced Non–Small Cell Lung Cancer is one of the most sought after conferences in the United States. This is because lung cancer is the cause for one third of all the cancer related deaths. Participants will learn about recognition of tumor characteristics, emerging role for preservation therapy in extending survival, improvement of novel targeted and chemotherapeutic agents. The attendees will also get a chance to review emerging clinical trial data that evaluate the role to assess histological considerations, biomarker analyses in treatment decision making, discuss the role of maintenance therapy in the treatment of patients with non–small cell lung cancer (NSCLC).Partakers will learn different topics from the experts and also will get the opportunity to share their knowledge and experience in this conference. The event will include case studies, interactive question-and-answer sessions, discussions, presentations.
The conference would cover the topics mentioned below:
- Evaluate recent studies investigating the utility of molecular markers as predictors of treatment response or resistance to specific agents and employ proven markers to develop individual treatment plans for patients with NSCLC.
- Assess and apply histological considerations for maximizing the safety and benefit associated with chemotherapy and targeted agents in the treatment of patients with NSCLC.
- Discuss the role of maintenance therapy in the treatment of patients with NSCLC.
The visitors at Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non–Small Cell Lung Cancer would include:
- Other healthcare professionals
- Advanced practitioners
- Physician assistants
- Medical oncologists
- Thoracic surgeons